BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15382062)

  • 21. Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol.
    Youk HJ; Lee E; Choi MK; Lee YJ; Chung JH; Kim SH; Lee CH; Lim SJ
    J Control Release; 2005 Sep; 107(1):43-52. PubMed ID: 16081183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. alpha-Tocopheryl succinate-induced apoptosis in human gastric cancer cells is modulated by ERK1/2 and c-Jun N-terminal kinase in a biphasic manner.
    Zhao Y; Zhao X; Yang B; Neuzil J; Wu K
    Cancer Lett; 2007 Mar; 247(2):345-52. PubMed ID: 16839662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-tocopheryl succinate induces DR4 and DR5 expression by a p53-dependent route: implication for sensitisation of resistant cancer cells to TRAIL apoptosis.
    Tomasetti M; Andera L; Alleva R; Borghi B; Neuzil J; Procopio A
    FEBS Lett; 2006 Apr; 580(8):1925-31. PubMed ID: 16529749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. alpha-Tocopheryl succinate causes mitochondrial permeabilization by preferential formation of Bak channels.
    Prochazka L; Dong LF; Valis K; Freeman R; Ralph SJ; Turanek J; Neuzil J
    Apoptosis; 2010 Jul; 15(7):782-94. PubMed ID: 20217235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA.
    Anderson K; Simmons-Menchaca M; Lawson KA; Atkinson J; Sanders BG; Kline K
    Cancer Res; 2004 Jun; 64(12):4263-9. PubMed ID: 15205340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular and molecular effects of alpha-tocopheryloxybutyrate: lessons for the design of vitamin E analog for cancer prevention.
    Wu Y; Zu K; Ni J; Yeh S; Kasi D; James NS; Chemler S; Ip C
    Anticancer Res; 2004; 24(6):3795-802. PubMed ID: 15736414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by alpha-tocopheryl succinate in human prostate cancer cells.
    Zu K; Hawthorn L; Ip C
    Mol Cancer Ther; 2005 Jan; 4(1):43-50. PubMed ID: 15657352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria.
    Yu W; Sanders BG; Kline K
    Cancer Res; 2003 May; 63(10):2483-91. PubMed ID: 12750270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-tocopheryl succinate inhibits autophagic survival of prostate cancer cells induced by vitamin K3 and ascorbate to trigger cell death.
    Tomasetti M; Nocchi L; Neuzil J; Goodwin J; Nguyen M; Dong L; Manzella N; Staffolani S; Milanese C; Garrone B; Alleva R; Borghi B; Santarelli L; Guerrieri R
    PLoS One; 2012; 7(12):e52263. PubMed ID: 23272231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of Ca2+ and ROS in alpha-tocopheryl succinate-induced mitochondrial permeabilization.
    Gogvadze V; Norberg E; Orrenius S; Zhivotovsky B
    Int J Cancer; 2010 Oct; 127(8):1823-32. PubMed ID: 20104525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. alpha-Tocopheryl succinate inhibits proliferation of mesothelioma cells by selective down-regulation of fibroblast growth factor receptors.
    Stapelberg M; Tomasetti M; Alleva R; Gellert N; Procopio A; Neuzil J
    Biochem Biophys Res Commun; 2004 Jun; 318(3):636-41. PubMed ID: 15144885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II.
    Dong LF; Low P; Dyason JC; Wang XF; Prochazka L; Witting PK; Freeman R; Swettenham E; Valis K; Liu J; Zobalova R; Turanek J; Spitz DR; Domann FE; Scheffler IE; Ralph SJ; Neuzil J
    Oncogene; 2008 Jul; 27(31):4324-35. PubMed ID: 18372923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effective molecular form of alpha-tocopheryl succinate in inducing apoptosis of SGC-7901 cells].
    Li HW; Zhao L; Wu K
    Wei Sheng Yan Jiu; 2005 Mar; 34(2):149-51. PubMed ID: 15952647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer.
    Hahn T; Szabo L; Gold M; Ramanathapuram L; Hurley LH; Akporiaye ET
    Cancer Res; 2006 Oct; 66(19):9374-8. PubMed ID: 17018590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gamma- and delta-tocotrienols exert a more potent anticancer effect than alpha-tocopheryl succinate on breast cancer cell lines irrespective of HER-2/neu expression.
    Pierpaoli E; Viola V; Pilolli F; Piroddi M; Galli F; Provinciali M
    Life Sci; 2010 Apr; 86(17-18):668-75. PubMed ID: 20188744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications.
    Greco E; Basso D; Fadi E; Padoan A; Fogar P; Zambon CF; Navaglia F; Bozzato D; Moz S; Pedrazzoli S; Plebani M
    Pancreas; 2010 Jul; 39(5):662-8. PubMed ID: 20562578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin E analogues and immune response in cancer treatment.
    Tomasetti M; Neuzil J
    Vitam Horm; 2007; 76():463-91. PubMed ID: 17628186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-tocopheryl succinate, in contrast to alpha-tocopherol and alpha-tocopheryl acetate, inhibits prostaglandin E2 production in human lung epithelial cells.
    Lee E; Choi MK; Lee YJ; Ku JL; Kim KH; Choi JS; Lim SJ
    Carcinogenesis; 2006 Nov; 27(11):2308-15. PubMed ID: 16714329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective cancer cell killing by alpha-tocopheryl succinate.
    Neuzil J; Weber T; Gellert N; Weber C
    Br J Cancer; 2001 Jan; 84(1):87-9. PubMed ID: 11139318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression.
    Wang XF; Birringer M; Dong LF; Veprek P; Low P; Swettenham E; Stantic M; Yuan LH; Zobalova R; Wu K; Ledvina M; Ralph SJ; Neuzil J
    Cancer Res; 2007 Apr; 67(7):3337-44. PubMed ID: 17409443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.